Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs ▲ | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Davita Inc. | 2 | 0 | 0 | 0 | 135,15 € | 124,89 € | -7,59 % |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | 1,29 € | 3,70 € | 187,04 % |
| Bruker Corp. | 8 | 1 | 2 | 0 | 64,96 € | 84,02 € | 29,35 % |
| Repligen Corp. | 13 | 0 | 1 | 0 | 140,00 € | 184,76 € | 31,97 % |
| Merit Medical Systems | 17 | 0 | 4 | 0 | 74,50 € | 86,90 € | 16,64 % |
| CONMED Corp. | 11 | 1 | 1 | 0 | 68,00 € | 106,18 € | 56,15 % |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | 93,50 € | 124,85 € | 33,53 % |
| Myriad Genetics | 5 | 2 | 1 | 0 | 21,00 € | 25,14 € | 19,73 % |
| Neurocrine Bioscience | 31 | 0 | 8 | 0 | 124,65 € | 140,60 € | 12,80 % |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | 73,50 € | 75,94 € | 3,31 % |
| Amedisys Inc. | 14 | 0 | 1 | 0 | 86,50 € | 92,26 € | 6,66 % |
| United Therapeutics | 19 | 0 | 4 | 0 | 247,90 € | 287,40 € | 15,93 % |
| Exelixis Inc. | 18 | 0 | 3 | 0 | 18,72 € | 26,01 € | 38,96 % |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | 39,58 € | 47,17 € | 19,18 % |
| Insulet Corp. | 16 | 0 | 2 | 0 | 159,50 € | 215,54 € | 35,13 % |
| Amicus Therapeutics Inc. | 6 | 0 | 3 | 0 | 8,70 € | 17,78 € | 104,36 % |
| Masimo Corp. | 7 | 1 | 0 | 0 | 117,55 € | 147,62 € | 25,58 % |
| Ensign Group Inc. | 9 | 0 | 1 | 0 | 109,00 € | 116,99 € | 7,33 % |
| PTC Therapeutics Inc. | 15 | 8 | 3 | 3 | 31,80 € | 41,51 € | 30,54 % |
| Agios Pharmaceuticals Inc. | 6 | 0 | 1 | 0 | 35,20 € | 38,99 € | 10,76 % |
| Xencor Inc. | 10 | 1 | 1 | 0 | 21,20 € | 32,58 € | 53,67 % |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 1 | 0 | 35,40 € | 84,74 € | 139,39 % |
| Healthequity Inc. | 1 | 0 | 0 | 0 | 71,00 € | 79,00 € | 11,27 % |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | 93,06 € | - | - |
| Novocure Ltd | 1 | 1 | 0 | 0 | 20,39 € | - | - |